View Author
scopus: 24305166600

Beex, L.V.

(Louk Beex)


patient cancer breast group study breast cancer treatment control tamoxifen women tumor adjuvant result effect table therapy difference screening score survival chemotherapy prognostic lymph performance percent impairment value status number bc patients factor level base model control group model netherland dataset buserelin variable <.001 memory analysis trial disease mammography curve exemestane neuropsychological response estrogen cancer institute cognitively month breast cancer patients urokinase-type plasminogen activator premenopausal method lymph node status reference plasminogen test scores department lymph node-positive patients metastatic breast cancer center institute imaging research activator node-negative copyright 2004 massachusetts comparison mutation postmenopausal objective response rate domain lymph node-negative patients function breast examination dutch




6 Most Recent Publications

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors (Article)
Schilder, C.M. Seynaeve, C.M. Linn, S.C. Boogerd, W. Beex, L.V. Gundy, C.M. Nortier, J.W. Velde, C.J.H. van de Dam, F.S. van Schagen, S.B.
2010-11-01
The impact of different definitions and reference groups on the prevalence of cognitive impairment: A study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy (Article)
Schilder, C.M. Seynaeve, C.M. Linn, S.C. Boogerd, W. Gundy, C.M. Beex, L.V. Dam, F.S. van Schagen, S.B.
2010-04-01
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study (Article)
Schilder, C.M. Eggens, P.C. Seynaeve, C.M. Linn, S.C. Boogerd, W. Gundy, C.M. Beex, L.V. Dam, F.S. van Schagen, S.B.
2009-01-01
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition (Article)
Kriege, M. Oosterwijk, J.C. Tollenaar, R.A.E.M. Zonderland, H.M. Obdeijn, I.M. Manoliu, R.A. Beex, L.V. Rutgers, E.J. Kok, T. Peterse, H. Tilanus-Linthorst, M.M.A. Meijer, S. Koning, H.J. de Muller, S.H. Brekelmans, C.T. Boetes, C. Klijn, J.G.M. Besnard, P.E.
2004-01-01
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients (Article)
Look, M.P. Kueng, W. Kates, R. Magdelenat, H. Martin, P.M. Beex, L.V. Windbichler, G. Janicke, F. Spyratos, F. Peyrat , J.P. Ricolleau, G. Cufer, T. Klijn, J.G.M. Brunner, N. Meijer van Gelder, M.E. Bendahl, P.O. Ulm, K. Schmitt, M. Eppenberger-Castori, S. Sweep, C.G. Fiets, W.E. Duggan, C. Blankenstein, M.A. Broet, P. Borstnar, S. Daxenbichler, G. Foekens, J.A. O'Higgins, N. Duffy, M.J. Daver, A. Manders, P. Romain, S. Quillien, V. Harbeck, N. Eppenberger, U. Putten, W.L.J. van Ferno, M. Christensen, I.J. Lisboa, B.W. Thomssen, C.
2002-01-16
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study (Article)
Klijn, J.G.M. Piccart, M. Veyret, C. Wildiers, J. Jassem, J. Burghouts, J. Duchateau, L. Becquart, D. Mignolet, F. Seynaeve, C.M. Beex, L.V. Mauriac, L. Zijl, J.A. van
2000-01-01